Products Categories
| CAS No.: | 68-12-2 |
|---|---|
| Name: | N,N-Dimethylformamide |
| Article Data: | 258 |
| Cas Database | |
| Molecular Structure: | |
|
|
|
| Formula: | C3H7NO |
| Molecular Weight: | 73.0947 |
| Synonyms: | DMF;DMF(amide);DMFA;Dimethylformamide;Formamide,N,N-dimethyl-;N,N-Dimethylmethanamide;N-Formyldimethylamine;NSC5356;Virodene-P 058; |
| EINECS: | 200-679-5 |
| Density: | 0.884 g/cm3 |
| Melting Point: | -61 °C |
| Boiling Point: | 153 °C at 760 mmHg |
| Flash Point: | 57.8 °C |
| Solubility: | soluble in water |
| Appearance: | Clear colorless liquid |
| Hazard Symbols: |
 T
|
| Risk Codes: | 61-20/21-36 |
| Safety: | 53-45 |
| Transport Information: | UN 2265 3/PG 3 |
| PSA: | 20.31000 |
| LogP: | 0.34030 |
- 68122-57-6Rosin, polymer with p-tert-butylphenol, formaldehyde, pentaerythritol and tung oil
- 68122-70-3Soybean oil, ethylene glycol, pentaerythritol, dipentaerythritol, tripentaerythritol, phthalic anhhdride, maleic anhydride resin
- 68122-86-1Oniumcompounds, 4,5-dihydro-1-methyl-2-nortallow alkyl-1-(2-tallow amidoethyl)imidazolium, Me sulfates
- 68122-92-9Linseed oil, polymer with bisphenol A, 4-butylphenol, formaldehyde,glycerol, oiticica oil and tung oil
- 68123-06-81,3-Propanediamine,N1-[3-(octyloxy)propyl]-
- 68123-13-7Benzenaminium,3-[(4-amino-6-bromo-5,8-dihydro-1-hydroxy-8-imino-5-oxo-2-naphthalenyl)amino]-N,N,N-trimethyl-,chloride (1:1)
- 68123-16-02-Propenoic acid, 2-methyl-, telomer with bromotrichloromethane, 1,3-butadiene and ethenylbenzene
- 68123-29-5Trizma carbonate
- 68123-30-87H-Furo(3,2-g)(1)benzopyran-7-one, 2,3-dihydro-9-hydroxy-
- 68123-41-1Benzoxazolium,3-(2-carboxyethyl)-2-[2-(phenylamino)ethenyl]-, bromide (1:1)
- 104146-10-3GCLE
- 209414-07-3
- 2759-28-61-Benzylpiperazine
- 81409-90-7Cabergoline
- 7664-39-3Hydrofluoric acid
- 79-06-1Acrylamide
- 61788-85-0Ethoxylated hydrogenated castor oil
- 124-07-2Octanoic acid
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
The N,N-Dimethylformamide, with the CAS registry number 68-12-2, is also known as Dimethyl formamide; Formyldimethylamine; DMF; DMFA. It belongs to the product categories of Organics;LEDA HPLC;Dimethylformamide (DMF).This chemical's molecular formula is C3H7NO and molecular weight is 73.09. What's more,Its systematic name is N,N-Dimethylformamide.It is a Clear colorless liquid.Slightly less dense than water. Vapors heavier than air. Toxic by inhalation or skin absorption. May irritate eyes,skin and nose,May cause nausea.When you use it,Avoid exposure - obtain special instruction before use.In case of accident or if you feel unwell, seek medical advice immediately (show label where possible).
Physical properties about N,N-Dimethylformamide are:
(1)ACD/LogP: -0.829; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.83; (4)ACD/LogD (pH 7.4): -0.83; (5)ACD/BCF (pH 5.5): 1.00; (6)ACD/BCF (pH 7.4): 1.00; (7)ACD/KOC (pH 5.5): 8.43; (8)ACD/KOC (pH 7.4): 8.43; (9)#H bond acceptors: 2; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 0; (12)Index of Refraction: 1.396; (13)Molar Refractivity: 19.856 cm3; (14)Molar Volume: 82.628 cm3; (15)Surface Tension: 25.7189998626709 dyne/cm; (16)Density: 0.885 g/cm3; (17)Flash Point: 57.778 °C; (18)Enthalpy of Vaporization: 38.98 kJ/mol; (19)Boiling Point: 152.999 °C at 760 mmHg; (20)Vapour Pressure: 3.40300011634827 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES:CN(C)C=O;
(2)Std. InChI:InChI=1S/C3H7NO/c1-4(2)3-5/h3H,1-2H3;
(3)Std. InChIKey:ZMXDDKWLCZADIW-UHFFFAOYSA-N.
The toxicity data of N,N-Dimethylformamide as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| cat | LD50 | intraperitoneal | 500mg/kg (500mg/kg) | LIVER: OTHER CHANGES KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED) | British Journal of Industrial Medicine. Vol. 13, Pg. 51, 1956. |
| dog | LD50 | intravenous | 470mg/kg (470mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965. | |
| guinea pig | LD50 | intravenous | 1050mg/kg (1050mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965. | |
| guinea pig | LDLo | intraperitoneal | 4gm/kg (4000mg/kg) | LIVER: FATTY LIVER DEGERATION | American Industrial Hygiene Association Journal. Vol. 35, Pg. 21, 1974. |
| mouse | LC50 | inhalation | 9400mg/m3/2H (9400mg/m3) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE WEAKNESS LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial Chemical Substances. For English translation, see TNICS*. Vol. 1, Pg. 54, 1961. |
| mouse | LD50 | intramuscular | 3900mg/kg (3900mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965. | |
| mouse | LD50 | intraperitoneal | 650mg/kg (650mg/kg) | Cancer Chemotherapy Reports. Vol. 30, Pg. 9, 1963. | |
| mouse | LD50 | intravenous | 2500mg/kg (2500mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965. | |
| mouse | LD50 | oral | 2900mg/kg (2900mg/kg) | National Technical Information Service. Vol. OTS0521148, | |
| mouse | LD50 | subcutaneous | 4500mg/kg (4500mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965. | |
| rabbit | LD50 | intraperitoneal | 1gm/kg (1000mg/kg) | LIVER: OTHER CHANGES BLOOD: CHANGES IN CELL COUNT (UNSPECIFIED) KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION | British Journal of Industrial Medicine. Vol. 13, Pg. 51, 1956. |
| rabbit | LD50 | intravenous | 1800mg/kg (1800mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965. | |
| rabbit | LD50 | oral | 5gm/kg (5000mg/kg) | National Technical Information Service. Vol. OTS0520699, | |
| rabbit | LD50 | skin | 4720mg/kg (4720mg/kg) | American Industrial Hygiene Association Journal. Vol. 30, Pg. 470, 1969. | |
| rat | LCLo | inhalation | 5000ppm/6H (5000ppm) | United States Patent Document. Vol. #5122301, | |
| rat | LD | skin | > 3160mg/kg (3160mg/kg) | National Technical Information Service. Vol. OTS0516779, | |
| rat | LD50 | intraperitoneal | 1400mg/kg (1400mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: MUSCLE WEAKNESS | British Journal of Industrial Medicine. Vol. 13, Pg. 51, 1956. |
| rat | LD50 | intravenous | 2gm/kg (2000mg/kg) | Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967. | |
| rat | LD50 | oral | 2800mg/kg (2800mg/kg) | Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967. | |
| rat | LD50 | subcutaneous | 3800mg/kg (3800mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 15, Pg. 618, 1965. | |
| rat | LD50 | unreported | > 3gm/kg (3000mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 18, Pg. 645, 1968. |
-
Premium Related Products
